MedPath

CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder
Substance Use Disorders
Interventions
Behavioral: cognitive behavioral therapy for treating ADHD symptoms
Registration Number
NCT01431235
Lead Sponsor
Arkin
Brief Summary

The purpose of this study is to determine if cognitive behavioral therapy is effective in treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.

Detailed Description

Attention Deficit Hyperactivity Disorder(ADHD) is an important comorbid condition in patients with substance use disorders (SUD). The prevalence of ADHD in patients with SUD is estimated 23%, and ADHD is associated with an untoward prognosis of SUD. However, adequate treatment programs for patients with ADHD and SUD are not available. Results of medication trials for patients with ADHD and SUD are disappointing, and cognitive behavioral therapy (CBT) has not yet been investigated in this population. In patients with ADHD without comorbid SUD, the results of CBT in randomized trials are positive. The purpose of this study is to investigate if CBT is effective in treating ADHD symptoms in patients with ADHD and SUD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
184
Inclusion Criteria
  • substance use disorder
  • ADHD
  • able to comply with study activities
Exclusion Criteria
  • severe neurological or psychiatric diseases (for example Parkinson, dementia, psychosis, bipolar depression) which require medication
  • unable to read or write Dutch language

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
addiction treatment and ADHD treatmentcognitive behavioral therapy for treating ADHD symptoms10 sessions cognitive behavioral therapy on addiction treatment combined with 5 sessions on ADHD treatment.
Primary Outcome Measures
NameTimeMethod
self reported ADHD symptoms6 months

Dutch self report list of ADHD symptoms by Kooij and Buitelaar

Secondary Outcome Measures
NameTimeMethod
TIC-P6 months

health care consumption and production loss in relation to mental health problems

Stroop task6 months

neuropsychological measure

Beck Anxiety Inventory6 months

Self reported anxiety symptoms

Time Line Follow Back method6 months

self-reported alcohol and drug use

EQ-56 months

Self reported quality of living

urine checks6 months

urine checks on drug use

BART task6 months

neuropsychological task on risk taking behavior

Beck depression inventory6 months

self reported depression symptoms

Tower of London task6 months

neuropsychological task

Trial Locations

Locations (1)

Arkin

🇳🇱

Amsterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath